Help Protect Patient Access to Allergen Immunotherapy in Georgia

I am writing in support of Resolution 324C.26 — Protecting Patient Access to Allergen Immunotherapy from Restrictive Practices of Georgia State-Regulated Health Plans. As a [specialty] physician practicing in [city, Georgia], I have seen firsthand how restrictive insurance policies by Georgia state-regulated health plans impact patients who would benefit from allergen immunotherapy. [Add a brief personal example if you have one — e.g., patients denied coverage, faced with excessive prior authorization hurdles, or unable to complete a course of therapy.] Allergen immunotherapy is evidence-based, cost-effective, and addresses the underlying cause of allergic disease rather than simply masking symptoms. When health plans use prior authorization delays, step-therapy mandates, or arbitrary dose limits to obstruct access, patients suffer — and the long-term costs of uncontrolled allergic disease to the healthcare system increase. I strongly support MAG taking a clear position in favor of protecting patient access to allergen immunotherapy in Georgia and urging state legislators and insurance regulators to adopt guardrails that prevent these restrictive practices. I urge the Medical Association of Georgia to adopt Resolution 324C.26. [Your Name, MD] [Specialty] [Practice Name] [City, Georgia]